DD153689A5 - Verfahren zur herstellung eines sterisch gehinderten aminsalzes einer 6,7-dihalogen-3,4-dihydro-3-oxo-2-chinoxalincarbonsaeure - Google Patents
Verfahren zur herstellung eines sterisch gehinderten aminsalzes einer 6,7-dihalogen-3,4-dihydro-3-oxo-2-chinoxalincarbonsaeure Download PDFInfo
- Publication number
- DD153689A5 DD153689A5 DD80224744A DD22474480A DD153689A5 DD 153689 A5 DD153689 A5 DD 153689A5 DD 80224744 A DD80224744 A DD 80224744A DD 22474480 A DD22474480 A DD 22474480A DD 153689 A5 DD153689 A5 DD 153689A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- oxo
- dihydro
- acid
- salt
- adamantylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/088,275 US4252954A (en) | 1979-10-25 | 1979-10-25 | Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD153689A5 true DD153689A5 (de) | 1982-01-27 |
Family
ID=22210429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD80224744A DD153689A5 (de) | 1979-10-25 | 1980-10-24 | Verfahren zur herstellung eines sterisch gehinderten aminsalzes einer 6,7-dihalogen-3,4-dihydro-3-oxo-2-chinoxalincarbonsaeure |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4252954A (it) |
| EP (1) | EP0029658A1 (it) |
| JP (1) | JPS5681569A (it) |
| AU (1) | AU6351280A (it) |
| BE (1) | BE885793A (it) |
| CA (1) | CA1149381A (it) |
| CS (1) | CS212304B2 (it) |
| DD (1) | DD153689A5 (it) |
| DK (1) | DK449780A (it) |
| ES (1) | ES496210A0 (it) |
| FI (1) | FI803294L (it) |
| FR (1) | FR2467848A1 (it) |
| GB (1) | GB2061936A (it) |
| GR (1) | GR69994B (it) |
| IL (1) | IL61313A0 (it) |
| IT (1) | IT1134009B (it) |
| PL (1) | PL227421A1 (it) |
| PT (1) | PT71939B (it) |
| YU (1) | YU268880A (it) |
| ZA (1) | ZA806437B (it) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD281614A5 (de) * | 1988-09-02 | 1990-08-15 | Univ Berlin Humboldt | Verfahren zur herstellung von virostatisch wirksamendiazinsubstituierten 1-adamantanen |
| WO1992011245A1 (en) * | 1990-12-20 | 1992-07-09 | Warner-Lambert Company | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity |
| AU744540B2 (en) * | 1997-09-01 | 2002-02-28 | Kyorin Pharmaceutical Co. Ltd. | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both |
| EP1608319A4 (en) | 2003-04-03 | 2007-02-28 | Univ California | IMPROVED HEMMER FOR SOLUBLE EPOXY HYDROLASE |
| JP2007532484A (ja) | 2004-03-16 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法 |
| CA2584342C (en) | 2004-10-20 | 2013-04-30 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| TW200808723A (en) | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| EP2528604B1 (en) | 2010-01-29 | 2017-11-22 | The Regents of the University of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| WO2012045280A1 (en) * | 2010-10-08 | 2012-04-12 | Novartis Ag | Salts and polymorphs of sulfamide ns3 inhibitors |
| JP6406159B2 (ja) | 2015-08-04 | 2018-10-17 | 株式会社デンソー | 車載表示制御装置、車載表示制御方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3355355A (en) * | 1965-02-05 | 1967-11-28 | Smith Kline French Lab | Antiviral cycloalkylamine compositions and method |
| DE1770697C3 (de) * | 1967-07-06 | 1981-04-23 | Dupher International Research B.V., Weesp | 2,2-(N-Methyl-2-azatetramethylen)- -adamantan, dessen Salze, Verfahren zu deren Herstellung und Arzneimittel |
| GB1438349A (en) * | 1973-09-13 | 1976-06-03 | Post Office | Conductor assemblies for cables |
| US4181724A (en) * | 1978-09-11 | 1980-01-01 | The Upjohn Company | Quinoxalinone compounds useful for expanding the lumina or air passages in mammals |
| GR72941B (it) * | 1978-10-20 | 1984-01-16 | Lilly Co Eli |
-
1979
- 1979-10-25 US US06/088,275 patent/US4252954A/en not_active Expired - Lifetime
-
1980
- 1980-10-20 IL IL61313A patent/IL61313A0/xx unknown
- 1980-10-20 PT PT71939A patent/PT71939B/pt unknown
- 1980-10-20 AU AU63512/80A patent/AU6351280A/en not_active Abandoned
- 1980-10-20 BE BE1/9993A patent/BE885793A/fr unknown
- 1980-10-20 FI FI803294A patent/FI803294L/fi not_active Application Discontinuation
- 1980-10-20 CA CA000362726A patent/CA1149381A/en not_active Expired
- 1980-10-20 ZA ZA00806437A patent/ZA806437B/xx unknown
- 1980-10-20 FR FR8022412A patent/FR2467848A1/fr not_active Withdrawn
- 1980-10-21 YU YU02688/80A patent/YU268880A/xx unknown
- 1980-10-21 PL PL22742180A patent/PL227421A1/xx unknown
- 1980-10-23 IT IT25538/80A patent/IT1134009B/it active
- 1980-10-23 ES ES496210A patent/ES496210A0/es active Granted
- 1980-10-23 GR GR63209A patent/GR69994B/el unknown
- 1980-10-23 GB GB8034218A patent/GB2061936A/en not_active Withdrawn
- 1980-10-23 CS CS807188A patent/CS212304B2/cs unknown
- 1980-10-23 EP EP80303761A patent/EP0029658A1/en not_active Withdrawn
- 1980-10-24 JP JP15001480A patent/JPS5681569A/ja active Pending
- 1980-10-24 DK DK449780A patent/DK449780A/da not_active Application Discontinuation
- 1980-10-24 DD DD80224744A patent/DD153689A5/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2061936A (en) | 1981-05-20 |
| US4252954A (en) | 1981-02-24 |
| PL227421A1 (it) | 1981-06-19 |
| DK449780A (da) | 1981-04-26 |
| ES8205207A1 (es) | 1981-10-01 |
| IT1134009B (it) | 1986-07-24 |
| GR69994B (it) | 1982-07-23 |
| PT71939A (en) | 1980-11-01 |
| ES496210A0 (es) | 1981-10-01 |
| EP0029658A1 (en) | 1981-06-03 |
| FI803294L (fi) | 1981-04-26 |
| ZA806437B (en) | 1982-05-26 |
| CA1149381A (en) | 1983-07-05 |
| CS212304B2 (en) | 1982-03-26 |
| FR2467848A1 (fr) | 1981-04-30 |
| YU268880A (en) | 1983-02-28 |
| IT8025538A0 (it) | 1980-10-23 |
| PT71939B (en) | 1981-08-31 |
| IL61313A0 (en) | 1980-12-31 |
| AU6351280A (en) | 1981-04-30 |
| BE885793A (fr) | 1981-04-21 |
| JPS5681569A (en) | 1981-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1795769A1 (de) | Tetrahydrohomopyrimidazolderivate, deren saeureadditionssalze und quaternaeren salze sowie verfahren zu deren herstellung | |
| DE69204662T2 (de) | Poly-4-aminopyrrole-2-carboxamide derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| CH656875A5 (de) | Amide von carbonsaeuren und ihre derivate. | |
| DE1593272A1 (de) | Verfahren zur Herstellung von Halogen-Tetracyclinen | |
| DE4217952A1 (de) | Chinoxalin-2,3(1H,4H)-dione | |
| DD153689A5 (de) | Verfahren zur herstellung eines sterisch gehinderten aminsalzes einer 6,7-dihalogen-3,4-dihydro-3-oxo-2-chinoxalincarbonsaeure | |
| DD146705A5 (de) | Verfahren zur herstellung von 3,4-dihydro-3-oxo-2-chinoxalinen | |
| EP0003029A2 (de) | Neue 2-Oxo-1-pyrrolidinessigsäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und deren Herstellung | |
| DE2044172C3 (de) | Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE2159361A1 (de) | Nitrofuranderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| DE1795022A1 (de) | Heterocyclische Verbindungen und Verfahren zu ihrer Herstellung | |
| DE2052719A1 (de) | Verfahren zur Herstellung von neuen 5 Nitrofuryldenvaten | |
| DE1965711C3 (de) | l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| CH616650A5 (it) | ||
| DE3423003A1 (de) | Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| CH635342A5 (de) | Verfahren zur herstellung von neuen octahydro-indolo(2,3-a)-chinolizinen. | |
| DE2035797A1 (de) | Neue Nitrofurandenvate , ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| EP0088986A2 (de) | Bicyclische Phenolether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DE1235929B (de) | Verfahren zur Herstellung von 2-(2'-Pyrazinyl)-benzimidazol und seinen Salzen | |
| DE2609574B2 (de) | 1-(4-fluor-3-trifluormethylthio- phenyl)-piperazin, dessen salze, verfahren zu dessen herstellung und arzneimittel | |
| DD246299A5 (de) | Verfahren zur herstellung n-substituierter anziridin-2-carbonsaeurederivaten | |
| EP0003286A2 (de) | Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE2711945A1 (de) | Neue benzimidazol-2-carbamat-derivate, verfahren zu deren herstellung und diese enthaltende zusammensetzungen | |
| DE3245950A1 (de) | Verfahren zur herstellung substituierter pyridine | |
| DE3031842A1 (de) | N-substituierte brenztraubensaeurehydrazone, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |